Amundi
IOVA icon

Amundi’s Iovance Biotherapeutics IOVA Stock Holding History

Amundi’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,932
Closed -$64.2K – 2078
2023
Q1 		$64.2K Hold
10,932
– – ﹤0.01% 1841
2022
Q4 		$67.1K Sell
10,932
-6,781
-38% -$52.9K ﹤0.01% 1660
2022
Q3 		$175K Buy
17,713
+10,932
+161% +$126K ﹤0.01% 1473
2022
Q2 		$86K Sell
6,781
-1,503
-18% -$19.7K ﹤0.01% 1474
2022
Q1 		$151K Hold
8,284
– – ﹤0.01% 1417
2021
Q4 		$126K Buy
8,284
+684
+9% +$15.1K ﹤0.01% 1541
2021
Q3 		$187K Hold
7,600
– – ﹤0.01% 1448
2021
Q2 		$198K Buy
+7,600
New +$198K ﹤0.01% 1379

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return